COVID-19 inactivated booster vaccines elicit strong protection against SARS-CoV-2 wild-type and Omicron variant in patients with breast cancer

Xiaomeng Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongzhe Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Frontiers in Medicine
April 1, 2025
10.3389/fmed.2025.1516492
Cited by 0

Related Papers

Development and validation of diagnostic and activity-assessing models for relapsing polychondritis based on laboratory parameters
|Frontiers in Immunology|2023|7
Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment
|BMC Immunology|2021|4